Hostname: page-component-78c5997874-j824f Total loading time: 0 Render date: 2024-11-10T21:14:29.176Z Has data issue: false hasContentIssue false

The effect of clozapine on adverse incidents in a low-secure challenging behaviour unit

Published online by Cambridge University Press:  10 April 2007

M Dominic Beer*
Affiliation:
Consultant Psychiatrist in Challenging Behaviour and Intensive Care Psychiatry, Oxleas NHS Trust and Honorary Senior Lecturer, Division of Psychological Medicine, Institute of Psychiatry, University of London
Al Aditya Khan
Affiliation:
SHO in Psychiatry, Oxleas NHS Trust
Kalaanithi Ratnajothy
Affiliation:
Head of Research and Development, Oxleas NHS Trust, Kent, UK
*
Correspondence to: Dr M.D. Beer, Bracton Centre, Oxleas NHS Trust, Bracton Lane, Dartford, Kent DA2 7AF, UK. E-mail: Dominic.Beer@oxleas.nhs.uk
Get access

Abstract

Background: Previous studies have shown that as well as being an effective antipsychotic, clozapine reduced aggressive and violent incidents. Most of the studies measured the length of time the patients were on clozapine, or the dose of the clozapine when the effectiveness was evaluated.

Method: A retrospective audit was designed to see the effectiveness of clozapine in reducing incidents in a low-secure challenging behaviour unit. The number of incidents was calculated pre and post the date when clozapine serum level reached the therapeutic level of 0.35μg/l. Then, the number of incidents per month (incidents/month ratio) before and after reaching the therapeutic level was calculated.

Results: The number of incidents per month was reduced by over 75%. Before serum clozapine level reached 0.35μg/l the number of incidents/month/patient was 1.22 and after reaching 0.35μg/l, it was 0.26 (p=0.004).

Conclusions: The use of clozapine reduced the number of adverse incidents by 75%. The monitoring of serum levels was found to be clinically useful.

Type
Research Article
Copyright
Copyright © NAPICU 2007

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)